UroGen Pharma Ltd.

NASDAQ: URGN
Share price (3/28/25): $11.20
Market cap (3/28/25): $516 million

Warning: Large portions of this site require JavaScript enabled in order to function properly. Please make sure JavaScript is enabled in your browser.

Please let us know at support@bamsec.com if you have any questions or concerns.

Search in Documents

Key Exhibits

External Links

Financials Filter

ended 12/31/24 FY 2024

ended 09/30/24 Q3

ended 06/30/24 Q2

ended 03/31/24 Q1

ended 12/31/23 FY 2023 – amended

Prospectuses and Registrations Filter

Registration of securities for employees

Prospectus supplement for primary offering

Prospectus supplement for primary offering

Registration of securities for employees

Shelf registration

Ownership Filter

Menora Mivtachim Holdings Ltd.

Adage Capital Management, L.P.

Schoenberg Mark

Smith Jason Drew

News Filter

Reports Fourth Quarter and Full Year 2024 Financial Results and Announces Updated 18-Month Duration of Response (DOR) of 80.6% From the Phase 3 ENVISION Trial of UGN-102

Material Definitive Agreement, Unregistered Sales of Equity Securities

Investor Presentation

Reports 2024 Third Quarter Financial Results and Business Highlights, Including the Potential Launch of UGN-102 in 2025

Change in Directors, Officers or Compensation, Financial Statements or Exhibits

Proxies Filter

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Definitive proxy

Additional info about upcoming vote

Other Filter

Scanned paper annual report submission

Letter from the SEC

Correspondence with the SEC

Letter from the SEC

Notice of effectiveness